Publications in collaboration with researchers from Universitat de València (3)

2022

  1. The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure

    Cardiovascular research, Vol. 118, Núm. 6, pp. 1466-1478

2020

  1. Filamin C variants are associated with a distinctive clinical and immunohistochemical arrhythmogenic cardiomyopathy phenotype

    International Journal of Cardiology, Vol. 307, pp. 101-108

  2. RNA sequencing-based transcriptome profiling of cardiac tissue implicates novel putative disease mechanisms in FLNC-associated arrhythmogenic cardiomyopathy

    International Journal of Cardiology, Vol. 302, pp. 124-130